NovaQuest Capital Management, L.L.C.

Patrick Jordan is Managing Partner at NovaQuest Capital Management and has worked in the life sciences sector for more than 25 years. His career includes roles as a CEO overseeing the development and launch of an FDA-approved therapy, as an executive with global responsibilities at a contract research organization, and in private equity, where he and his partners managed over $2 billion in investments in late-stage drugs and biopharma commercial products. His work has spanned patient recruitment, clinical research tools drawing on integrated patient data, and the management of global biopharma partnerships.

Chris Mauney is Vice President at NovaQuest Capital Management. Holding both a PhD and an MBA, Mauney works as a biomedical scientist and pharmaceutical product developer focused on translating discovery research into new health interventions.